DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Accord healthcare
03 2Accure Labs
04 1Apotex Inc
05 1Assia Chemical Industries Ltd
06 1Aurobindo Pharma Limited
07 2Bluepharma
08 12Boucher & Muir
09 1Central Procurement & Supplies Unit
10 1Eugia Pharma
11 2Eurolab
12 2GSK
13 2Glenmark Pharmaceuticals
14 2Intas Pharmaceuticals
15 2Laboratorio Eczane Pharma
16 1Lotus Support Services S.R.L.
17 2Newbury Pharmaceuticals Ab
18 21Novartis Pharmaceuticals Corporation
19 2Novartis South Africa (Pty) Ltd
20 1Novugen
21 2PharOS Ltd
22 2Pharmacare Premium
23 1Pharmascience Inc.
24 2Pinnacle Life Science
25 2Pluviaendo
26 4STADA Arzneimittel
27 2Sakar Healthcare
28 4Sandoz B2B
29 2Spirig Healthcare
30 1Sun Pharmaceutical Industries Limited
31 1Teva Pharmaceutical Industries
32 2TherDose Pharma
33 3Torrent Pharmaceuticals Limited
34 2Zentiva
01 7FCT
02 40Film Coated Tablet
03 2Oral Solid Dosage Form
04 5TABLET
05 8TABLET;ORAL
06 6Tablet
07 4Tablets
08 24Blank
01 6Allowed
02 12Approved
03 7Authorised
04 8Authorized
05 1DISCN
06 7Generic
07 2Lead Market Dossiers- Under Development
08 2Originator
09 3Prescription
10 7RX
11 1Withdrawn
12 40Blank
01 1EUGIA-PAZOPANIB
02 6PAZOPANIB HYDROCHLORIDE
03 1PAZOTEV 400
04 1PMS-PAZOPANIB
05 1Pazitorz 200 mg
06 1Pazitorz 400 mg
07 2Pazopane
08 1Pazopanib 200 Eurolab
09 1Pazopanib 400 Eurolab
10 12Pazopanib ADVZ
11 4Pazopanib Accord
12 4Pazopanib Glenmark
13 2Pazopanib Hydrochloride
14 1Pazopanib Lotus
15 2Pazopanib Newbury
16 2Pazopanib Pharmacare
17 2Pazopanib Pharos
18 3Pazopanib Sandoz
19 1Pazopanib Sandoz film-coated tablets
20 2Pazopanib Spirig HC
21 4Pazopanib Stada
22 2Pazopanib Zentiva
23 1Pyzypi
24 3VOTRIENT
25 18Votrient
26 1Votrient 200 mg
27 1Votrient 400 mg
28 16Blank
01 2Argentina
02 24Australia
03 3Canada
04 14India
05 8Malta
06 2Portugal
07 7South Africa
08 8Spain
09 12Sweden
10 6Switzerland
11 2Turkey
12 8USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Pazitorz 200 mg
Dosage Form : FCT
Dosage Strength : 200mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Pazitorz 400 mg
Dosage Form : FCT
Dosage Strength : 400mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217517
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-12-04
Application Number : 219034
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info : RX
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-04-23
Application Number : 218231
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 215837
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE
Packaging :
Approval Date : 2025-09-04
Application Number : 219922
Regulatory Info : RX
Registration Country : USA
